Table of Contents:
- Tyrosine kinase inhibitor discontinuation in patients with chronic myelogenous leukaemia: A retrospective study and review of the literature
- Stem cell-derived natural killer cell immunotherapy
- Belgian guidelines for diagnosis and treatment of chronic myelomonocytic leukaemia
- CAR-T cells: New developments and implications in lymphoma
- Managing complement deficiencies: Not as complex as it seems
- Non-substitutive strategies to improve haemophilia care in developing countries: Experience in Côte d’Ivoire
- New haematology reimbursements in Belgium
